HKD 1.1
(-0.9%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 869.23 Million CNY | 42195.6% |
2022 | 2.05 Million CNY | -0.62% |
2021 | 2.06 Million CNY | 11.69% |
2020 | 1.85 Million CNY | 234.58% |
2019 | 553.37 Thousand CNY | 30.64% |
2018 | 423.59 Thousand CNY | -99.14% |
2017 | 49.13 Million CNY | 189.89% |
2016 | 16.94 Million CNY | -57.75% |
2015 | 40.11 Million CNY | 198.35% |
2014 | 13.44 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 FY | 869.23 Million CNY | 42195.6% |
2023 Q2 | 1.87 Million CNY | -8.81% |
2023 Q4 | 869.23 Million CNY | 46280.31% |
2022 Q4 | 2.05 Million CNY | 17.41% |
2022 FY | 2.05 Million CNY | -0.62% |
2022 Q2 | 1.75 Million CNY | -15.36% |
2021 Q2 | 2.4 Million CNY | 29.68% |
2021 FY | 2.06 Million CNY | 11.69% |
2021 Q4 | 2.06 Million CNY | -13.87% |
2020 Q2 | 2.17 Million CNY | 293.43% |
2020 Q4 | 1.85 Million CNY | -14.96% |
2020 FY | 1.85 Million CNY | 234.58% |
2019 FY | 553.37 Thousand CNY | 30.64% |
2019 Q4 | 553.37 Thousand CNY | 0.0% |
2018 FY | 423.59 Thousand CNY | -99.14% |
2017 Q2 | 44.38 Million CNY | 161.89% |
2017 Q4 | 49.13 Million CNY | 10.69% |
2017 FY | 49.13 Million CNY | 189.89% |
2016 FY | 16.94 Million CNY | -57.75% |
2016 Q4 | 16.94 Million CNY | 0.0% |
2015 FY | 40.11 Million CNY | 198.35% |
2014 FY | 13.44 Million CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | -112.012% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 92.272% |